Product Information

OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1171 per EA under NDC 31722094901. Its NADAC has been published 370 times since Sep 4, 2019.

FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET

Oxycodone and Acetaminophen
$0.1171per EA
High Outlier
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

31722094901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207419

FDA Approved

3/22/2017

TE Code

AA

On Market Since

4/11/2017

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 370 times since Sep 4, 2019, and over the history we have for it it has risen 46.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1171 per EA
All-time high$0.1339 (Apr 16, 2025)
All-time low$0.0776 (May 20, 2020)
52-week high$0.1228
52-week low$0.1171
Median price$0.1024
Average price$0.1028
Largest weekly change+13.9% (Feb 22, 2023)
Weeks tracked370
Tracking sinceSep 4, 2019

Price History

1W

0.0%

1M

-2.1%

3M

-1.9%

6M

-2.5%

1Y

-4.7%

3Y

+9.9%

5Y

+38.8%

All

+46.1%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1171 per EA (NDC 31722094901), effective Sep 30, 2026.

How has the price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has risen 46.1%. It has been tracked across 370 weekly CMS publications since Sep 4, 2019.

What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since Sep 4, 2019, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0776 (May 20, 2020) to a high of $0.1339 (Apr 16, 2025), with a median of $0.1024 per EA.

Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.0864 per EA — about 26% below OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET.

Who manufactures OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?

OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 31722094901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.